Devices › Device types
FDA product code LOD · class 2 · Orthopedic
Bone cement: medical device reports filed with FDA
13,179 reports carry this product code, 1992–2026; 26 brands with a page.
- 13,179
- reports with this product code
- 0.1% of all MAUDE reports
- 310
- reports, 12 months to August 2026
- 399 in the 12 months before
- 22.1%
- classified as malfunction
- 62.3% across all reports
- 3.6%
- classified as death, as reported
- 0.9% across all reports
Product code LOD is FDA's classification for "Bone cement" (orthopedic panel), a class 2 device. 13,179 medical device reports carry this product code, 0.1% of the MAUDE database, from March 1992 to August 2026.
310 reports arrived in the 12 months to August 2026, down 22% from 399 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (73.8%), malfunction (22.1%) and death (3.6%). 26 brand names with a page on this site carry this code; the brands table is ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Brands with this product code
| Brand | Reports | Latest 12 months | Classified as death | Classified as malfunction |
|---|---|---|---|---|
| Smartset Gmv 40g Us Eo | 1,269 | 40 | 0% | 6.2% |
| Smartset Hv Bone Cement 40g | 1,108 | 3 | 0% | 8.1% |
| Smartset Mv 40g - Eo | 1,092 | 4 | 0.1% | 6.2% |
| Smartset Ghv Gentamicin 40g | 996 | 40 | 0.4% | 17.3% |
| Unknown Bone Cement | 942 | 37 | 0% | 3.8% |
| Unknown Depuy Cement | 370 | 0 | 0.3% | 0% |
| Depuy Cmw 2 20g | 350 | 15 | 0% | 6.6% |
| Depuy Cmw 1 40g | 297 | 0 | 1.3% | 3% |
| Simplex P-Japanese Twin Pack | 297 | 1 | 10.6% | 71.5% |
| Unknown Depuy Bone Cement | 278 | 0 | 0% | 0% |
| Depuy Cmw 3 40g | 228 | 0 | 1.8% | 8.8% |
| Smartset Mv Endurance 80g | 165 | 1 | 0% | 0.6% |
| Simplex P Full Dose 1 Pack | 164 | 1 | 3% | 56.4% |
| Depuy1 Gentamicin Cement 40g | 133 | 0 | 0.7% | 1.9% |
| Depuy/Cmw 2g | 21 | 4 | 0.6% | 4.3% |
| Zimmer | 6 | 0 | 2.8% | 17.2% |
| UNK Hip Bone Screw | 3 | 14 | 0% | 4% |
| Attune Fb Tib Base Sz 6 Cem | 2 | 10 | 0% | 1.4% |
| Kyphx Hv-R Bone Cement | 2 | 7 | 3.4% | 65.3% |
| Air Dermatome Handpiece | 1 | 0 | 0% | 67.3% |
| Attune Fb Tib Base Sz 4 Cem | 1 | 14 | 0% | 1.5% |
| Attune Rp Tib Base Sz 7 Cem | 1 | 7 | 0% | 2.2% |
| Mbt Cem Keel Tib Tray Sz2 5 | 1 | 6 | 0% | 0.3% |
| Pfc Sigma/Ov/Dome Pat 3peg 38 | 1 | 3 | 0.4% | 1.9% |
| Sig Mod Tib Tray Cem Cocr 3 | 1 | 3 | 0% | 0.6% |
| Unknown Depuy Tibial Tray | 1 | 0 | 0% | 0.2% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Manufacturers named
| Manufacturer (as written on reports) | Reports | Share |
|---|---|---|
| Depuy Cmw - 9610921 | 2,068 | 15.7% |
| Depuy Orthopaedics 1818910 | 1,473 | 11.2% |
| Depuy Cmw 9610921 | 1,370 | 10.4% |
| Depuy Cmw | 957 | 7.3% |
| Stryker Orthopaedics-Mahwah | 879 | 6.7% |
| Stryker Orthopaedics Limerick | 496 | 3.8% |
| Howmedica | 440 | 3.3% |
| Biomet France R L | 396 | 3% |
| Depuy Orthopaedics US | 306 | 2.3% |
| Depuy Ireland - 3015516266 | 167 | 1.3% |
| Zimmer Surgical | 118 | 0.9% |
| Zimmer | 66 | 0.5% |
| Depuy Orthopaedic 1818910 | 55 | 0.4% |
| Depuy Orthopaedics US 1818910 | 53 | 0.4% |
| Biomet | 37 | 0.3% |
Reports by month, five years
FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
Event type and report source
Event type
Who filed
Grey bar: all 26,136,888 MAUDE reports.
Device problems coded
| Device problem (FDA code) | Reports | Share |
|---|---|---|
| Loss of or failure to bond | 5,775 | 43.8% |
| Insufficient device problem information | 662 | 5% |
| Loosening of implant not related to bone-ingrowth | 448 | 3.4% |
| Loss of osseointegration | 321 | 2.4% |
| Loose or intermittent connection | 300 | 2.3% |
| Device operates differently than expectedthe device behaved unexpectedly | 288 | 2.2% |
| Breakthe device broke | 285 | 2.2% |
| Chemical problem | 261 | 2% |
| Loose | 223 | 1.7% |
| Migration or expulsion of device | 214 | 1.6% |
| Unsealed device packaging | 203 | 1.5% |
| Explanted | 160 | 1.2% |
| Device damaged prior to usethe device was damaged before use | 154 | 1.2% |
| Reactiona reaction, type not specified | 143 | 1.1% |
| Implant, removal of | 142 | 1.1% |
| Failure to adhere or bond | 121 | 0.9% |
| Tear, rip or hole in device packaging | 110 | 0.8% |
| Device difficult to setup or prepare | 102 | 0.8% |
| Fracturea broken bone | 96 | 0.7% |
| Nonstandard device | 95 | 0.7% |
Questions about bone cement reports
What is product code LOD?
FDA's classification code for "Bone cement", class 2, reviewed by the orthopedic panel. Every device report carries the product code of the device involved.
How many reports carry this code?
13,179 reports through August 2026, 310 of them in the latest 12 months.
Which brands appear most often?
Smartset Gmv 40g Us Eo (1,269), Smartset Hv Bone Cement 40g (1,108), Smartset Mv 40g - Eo (1,092), Smartset Ghv Gentamicin 40g (996) and Unknown Bone Cement (942). Widely used products collect more reports because more people use them.
Can the brands table be used to rank the devices?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." Brands differ in how many are in use, how long they have been sold and how reports are collected.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.